Search results
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 7 hours agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies ...
Researchers take step toward development of universal COVID-19 antibodies
Valley City Times Record· 7 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical ...
House Republicans’ Attempts to Attack Fauci Go Wildly Off Rails
The New Republic via Yahoo News· 3 days ago“No—I’m on the record, and I want to make sure that this is clear: that I developed a monoclonal ...
On a congressional COVID hearing, and weaponized uncertainty
Columbia Journalism Review· 6 hours agoAs the virus continued to spread, so did various versions of the theory. In February 2021, Facebook finally announced that it would remove any posts suggesting that the COVID
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 hour agoThe RSV market has altered substantially in recent years owing to the emergence of novel vaccines...
A Guide to Managing Covid This Summer
New York Times· 3 days agoKP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers for Disease Control and Prevention shows a small increase...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 3 days agoAnthony Fauci over his involvement in the response to the Covid-19 pandemic. Fauci was summoned...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 6 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...
MS Med Nearly Eliminates Disease Activity on MRI
Medscape· 1 day agoA second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data ...